Thank you, Guy Spigelman and the Amazon Web Services (AWS) Healthcare and Life Sciences team, for a great podcast! Our CEO Raviv Pryluk shared why PhaseV was founded and how our novel technology can reshape the way clinical trials are designed and conducted, providing much more efficient, precise, and successful trials. Listen on the Health Podcast Network or wherever you listen to your podcasts: https://lnkd.in/dsE8CBGM https://lnkd.in/dms-4V4v
We live in a golden age of innovation in drug development, but new medicines take far too long to get into the clinic due to our inefficient and costly clinical trial infrastructure. PhaseV leverages cutting-edge technologies like reinforcement and causal machine learning to advance adaptive trial design and execution. Their novel approach aims to improve trial success rates while maximizing efficiency. What's truly remarkable is their ability to detect hidden signals in data and extract actionable insights when analyzing clinical trial results. Guy Spigelman, EMEA lead for Healthcare & Life Sciences Startups, welcomes PhaseV's Co-Founder & CEO Raviv Pryluk to discuss: 🧬 How PhaseV identified clinical trials as ripe for innovation leveraging machine learning ⚡ How cutting-edge technologies like reinforcement learning and causal ML are transforming trial design 🔍 How PhaseV's causal ML extracts insights from complex biological data 🌐 Capitalizing on regulatory shifts post-COVID to usher in precision medicine ... and so much more 🔉 Listen on the Health Podcast Network, or wherever you listen to your podcasts: https://lnkd.in/eevzTP7t Learn more about: ➡️ PhaseV: phasevtrials.com ➡️ How healthcare & life sciences industry leaders leverage the cloud to accelerate health innovation: https://lnkd.in/eW3GGqc5 #AWSHealthPod #HealthcarePodcasts #ClinicalTrials #MachineLearning #LifeSciences #HealthTech AWS Startups AWS for Healthcare & Life Sciences Amazon Web Services (AWS) Elad Lev